A carregar...
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes
Sulfonylurea (SU) and dipeptidyl peptidase-4 (DPP-4) inhibitors are most common secondary agents that are added to metformin monotherapy. Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice and real-world data could help appropr...
Na minha lista:
| Publicado no: | Transl Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Clinical Pharmacology and Therapeutics
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7781806/ https://ncbi.nlm.nih.gov/pubmed/33425803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|